Isosorbide dinitrate and Bumex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isosorbide dinitrate (isosorbide dinitrate) and Bumex (bumetanide). Common drug interactions include headache among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Isosorbide dinitrate and Bumex. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Isosorbide dinitrate?

Isosorbide dinitrate has active ingredients of isosorbide dinitrate. It is often used in angina. eHealthMe is studying from 13,180 Isosorbide dinitrate users. Check the latest studies of Isosorbide dinitrate.

What is Bumex?

Bumex has active ingredients of bumetanide. It is often used in swelling. eHealthMe is studying from 9,210 Bumex users. Check the latest studies of Bumex.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 21, 2026

48 people who take Isosorbide dinitrate and Bumex together, and have interactions are studied.

Isosorbide dinitrate and Bumex drug interactions.

What are the common drug interactions of Isosorbide Dinitrate and Bumex, by gender? *:

female:

  1. Headache (pain in head)
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting
  4. Anaemia (lack of blood)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
  7. Fall
  8. Multiple injuries
  9. Neuropathy peripheral (surface nerve damage)
  10. Cardiac disorder

male:

  1. Cardiac failure congestive
  2. Cardiac arrest
  3. Renal failure chronic (long lasting kidney dysfunction)
  4. Rib fracture
  5. Subendocardial ischaemia
  6. Type 1 diabetes mellitus
  7. Type 2 diabetes mellitus
  8. Upper limb fracture
  9. Dizziness
  10. Drug ineffective

What are the common drug interactions of Isosorbide Dinitrate and Bumex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Pancreatitis (inflammation of pancreas)
  2. Papillary thyroid cancer
  3. Post procedural hypothyroidism
  4. Toxic nodular goitre (a thyroid gland that contains autonomously functioning thyroid nodules, with resulting excess thyroid hormone secretion)

40-49:

  1. Dehydration (dryness resulting from the removal of water)
  2. Diarrhoea
  3. Dizziness
  4. Duodenitis (inflammation of the duodenum)
  5. Dyslipidaemia (abnormal amount of lipids)
  6. Dyspnoea (difficult or laboured respiration)
  7. Electrolyte imbalance
  8. Endocarditis bacterial (an inflammation of the inner layer of the heart by bacterial infection)
  9. Eructation (release of gas from the digestive tract)
  10. Flatulence (flatus expelled through the anus)

50-59:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

60+:

  1. Contusion (a type of hematoma of tissue in which capillaries)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Chest pain
  5. Drug ineffective
  6. Dyspnoea (difficult or laboured respiration)
  7. Anaemia (lack of blood)
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Confusional state

What are the existing conditions these people have? *

  1. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 5 people, 10.42%
  2. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 8.33%
  3. Cardiac Disorder: 4 people, 8.33%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 8.33%
  5. High Blood Cholesterol: 3 people, 6.25%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide dinitrate and Bumex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isosorbide dinitrate and Bumex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isosorbide dinitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bumex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide dinitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bumex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide dinitrate and bumetanide (the active ingredients of Isosorbide dinitrate and Bumex, respectively), and Isosorbide dinitrate and Bumex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: